Oliver R. Baumann

Oliver R. Baumann is a certified banking economist and passionate entrepreneur who serves as Chairman and CEO at Xlife Sciences AG. He has held this position since 2020. He possesses a 17-year track record in investment banking combined with experience in entrepreneurship and the biotech industry.

His career began at Credit Suisse where he focused on alternative investments and research in biotech and medtech. He subsequently advised numerous start-ups and M&A transactions while serving as an active member on multiple boards of directors. Beyond his CEO role at Xlife Sciences, he also serves as CEO at Akira Trading GmbH, Chairman at Akira Holding AG, Director at Pecunia Solutions AG, Director at Veraxa Biotech AG, Director at Axenoll Life Sciences AG, and Co-Managing Director at Xrna Biotech GmbH.

Baumann's educational background includes a diploma in banking economics (Dipl. Bankwirtschafter) from HFBF Banking + Finance and attendance at KV Business School Zürich. He is driven by innovative thinking and motivated to transform the healthcare industry by making it more accessible while accelerating the discovery and release of new therapies and cures.

Career History

• CEO & Director, Xlife Sciences AG (2020–present)
• Investment advisor and alternative investments specialist, Credit Suisse (various years)
• Board Member, Belvoir Wealth Management AG
• CEO, Akira Trading GmbH (current)
• Director, Veraxa Biotech AG (current)

What Oliver Baumann could bring to his role at Xlife Sciences: Drawing on his deep expertise in biotech and medtech from his Credit Suisse years, combined with his hands-on entrepreneurial experience advising startups and managing M&A transactions across multiple life sciences ventures, Baumann is positioned to guide Xlife Sciences toward its stated goals of becoming a global incubator and accelerator capable of advancing innovation from universities into the healthcare sector.